Drug Shortage Report for BREVICON 1/35 TABLETS (28-DAY PACK)

Last updated on 2022-10-21 History
Report ID 168162
Drug Identification Number 02189062
Brand name BREVICON 1/35 TABLETS (28-DAY PACK)
Common or Proper name Brevicon 28
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ETHINYL ESTRADIOL NORETHINDRONE
Strength(s) 0.035MG 1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 28 DAYS PACK BLST
ATC code G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-10-17
Actual start date
Estimated end date 2022-10-21
Actual end date 2022-10-20
Shortage status Resolved
Updated date 2022-10-21
Company comments Available inventory is on preventative allocation. Other presentations available : BREVICON 1/0.035mg (21’S), BREVICON 0.5/0.035mg (21’s), BREVICON 0.5/0.035mg (28’s).
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-10-21 French Compare
v6 2022-10-21 English Compare
v5 2022-10-18 English Compare
v4 2022-10-13 French Compare
v3 2022-10-13 English Compare
v2 2022-08-29 French Compare
v1 2022-08-29 English Compare

Showing 1 to 7 of 7